Drugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer
- DOI
- 10.1016/j.ejca.2026.117794
- Published
- 2026-12
- Container
- European Journal of Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2026.117794,
title = {Drugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer},
author = {Aldo Caltavituro and Antonio Giordano and Carmine De Angelis and Roberto Buonaiuto and Jacopo Canzian and Martí Torres-Marcén and Francesco Schettini and Giampaolo Bianchini and Beatrice Taurelli Salimbeni and Mario Giuliano and Grazia Arpino and Luca Malorni and Michelino De Laurentiis and Carmen Criscitiello},
year = {2026},
journal = {European Journal of Cancer},
doi = {10.1016/j.ejca.2026.117794},
url = {https://doi.org/10.1016/j.ejca.2026.117794}
}RIS
TY - JOUR TI - Drugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer AU - Aldo Caltavituro AU - Antonio Giordano AU - Carmine De Angelis AU - Roberto Buonaiuto AU - Jacopo Canzian AU - Martí Torres-Marcén AU - Francesco Schettini AU - Giampaolo Bianchini AU - Beatrice Taurelli Salimbeni AU - Mario Giuliano AU - Grazia Arpino AU - Luca Malorni AU - Michelino De Laurentiis AU - Carmen Criscitiello PY - 2026 JO - European Journal of Cancer DO - 10.1016/j.ejca.2026.117794 UR - https://doi.org/10.1016/j.ejca.2026.117794 ER -
APA
Caltavituro, A., Giordano, A., Angelis, C. D., Buonaiuto, R., Canzian, J., Torres-Marcén, M., Schettini, F., Bianchini, G., Salimbeni, B. T., Giuliano, M., Arpino, G., Malorni, L., Laurentiis, M. D., & Criscitiello, C. (2026). Drugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.117794
Source records
- crossref · retrieved 2026-11-05T04:45:40.902Z